663 results on '"Roberts, Matthew J."'
Search Results
2. Prostate volume analysis in image registration for prostate cancer care: a verification study
3. Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management
4. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer
5. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent
6. Associations of objectively measured physical activity, sedentary time and cardiorespiratory fitness with adipose tissue insulin resistance and ectopic fat
7. Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer
8. High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints
9. Exploring Unmet Needs in Prostate Cancer Care: A Cross-sectional Descriptive Study
10. Reclassifying historical disasters: From single to multi-hazards
11. The Cost-Effectiveness of Germline BReast CAncer Gene Testing in Metastatic Prostate Cancer Followed by Cascade Testing of First-Degree Relatives of Mutation Carriers
12. The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer-related pathology: A single centre retrospective study
13. Etiology and management of urethral calculi: A systematic review of contemporary series
14. Reducing Bias and Quantifying Uncertainty in Fluorescence Produced by PCR
15. Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography
16. Uro-symphyseal Fistula: A Systematic Review to Inform a Contemporary, Evidence-based Management Framework
17. Using PSMA imaging for prognostication in localized and advanced prostate cancer
18. A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
19. Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more
20. Exercise as an anti-inflammatory Therapy in Axial Spondyloarthritis Therapeutic Intervention (EXTASI study): a randomised control trial
21. Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
22. Incorporating measurement variability when comparing sets of high-resolution mass spectra
23. Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications
24. Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics.
25. Prospective intra-individual blinded comparison of [18F]PSMA-1007 and [68 Ga]Ga-PSMA-11 PET/CT imaging in patients with confirmed prostate cancer
26. Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation
27. Cancer‐on‐Chip and Integrative Tumor Microenvironment Sensor Technologies for Progressing Precision Radiotherapy
28. Prostate tumour visualisation with PET: is image fusion with MRI the answer?
29. The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis
30. Lymph node classification in E-PSMA reporting guidelines for PSMA-PET
31. Bladder infusion versus standard catheter removal for trial of void: a systematic review and meta-analysis
32. HOW TO OFFER INCLUSIVE CARE FOR LGBTQ+ PATIENTS: Recognize inherent biases in practices and implement more supportive behavior to interact with members of this community respectfully
33. Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution
34. 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer
35. Pituitary Metastasis of Renal Cell Carcinoma Characterized by 18F–Prostate-Specific Membrane Antigen–1007 PET/CT
36. The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort
37. Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer
38. The Effectiveness of a Criteria-Led Discharge Initiative on the Length of Stay of Patients Who Underwent a Robotic-Assisted Laparoscopic Prostatectomy
39. Intra‐individual comparison of prostate‐specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis
40. Adipose inflammation: South Asian ethnicity and central obesity are independently associated with higher immune cell recruitment to adipose‐specific media: A pilot study in men
41. Infectious complications of prostate biopsy: winning battles but not war
42. Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
43. Television Viewing Time, Overweight, Obesity, and Severe COVID-19: A Brief Report From UK Biobank.
44. Variation in patient reported outcomes following radical prostatectomy: A bi-national registry-based study
45. Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer
46. 68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?
47. Subaerial and subglacial seismic characteristics of the largest measured jökulhlaup from the eastern Skaftá cauldron, Iceland
48. 68Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study
49. Are There Interindividual Responses of Cardiovascular Disease Risk Markers to Acute Exercise? A Replicate Crossover Trial
50. APPROXIMATING THE GENERALIZED SINGULAR VALUE EXPANSION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.